IndiaOne Finance - Company Dashboard

Governance Classic Home

Venus Remedies LtdPharmaceuticalsINE411B01019Consolidated₹1582.20+32.40 (+2.09%)Jun-26

Valuation

Market Cap₹2.11K Cr

TTM PE18.21x

Forward PE16.52x

PEG1.40

Book Value₹496.56

P/B3.19x

TTM EPS₹86.91

Fwd EPS₹95.80

TTM Revenue₹811.27 Cr

TTM PAT₹116.17 Cr

TTM EBITDA₹166.09 Cr

TTM EBIT₹139.83 Cr

Last Qtr PAT₹22.97 Cr

Last Qtr EBITDA₹34.19 Cr

Last Qtr EBIT₹27.42 Cr

Profitability

ROE17.50%

ROCE22.84%

TTM NPM14.32%

TTM EBITDA %20.47%

Curr OPM12.66%

Last OPM17.96%

Curr NPM—

Last NPM—

Curr EPS₹17.18

Last EPS₹35.53

Balance sheet

Equity₹13.37 Cr

Reserve₹650.38 Cr

Total Debt₹0.00 Cr

D/E0.00x

Interest %0.00%

Curr Interest₹0.00 Cr

Price / range

Close₹1582.20

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+2.09%

1W-2.11%

1M-13.04%

3M-9.02%

6M+76.62%

1Y+263.68%

2Y+355.24%

3Y+578.47%

5Y+238.98%

Diwali+109.20%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	178.80+35.6%	259.01	179.95	192.65	131.85	768.73
Other Income	2.55	4.64	2.41	1.68	8	11.45
Total Income	181.35+29.7%	263.65	182.36	194.33	139.85	780.18
Interest	0	0	0	0	0	0
Expenditure	-148.75-18.9%	-206.07	-149.55	-168.73	-125.15	-649.50
PBDT	0	0	0	0	0	0
EBITDA	36.56+189.0%	59.44	36.72	29.84	12.65	143.92
Depreciation	-6.51	-6.50	-6.32	-5.92	-5.95	-24.69
EBIT	30.05+348.5%	52.94	30.40	23.92	6.70	119.23
PBT	32.60+121.8%	57.58	32.81	25.60	14.70	130.68
Tax	-7.07	-14.11	-7.89	-6.36	-3.01	-31.37
Equity	13.37	13.37	0	0	13.37	13.37
OPM	17.98	21.84	18.23	13.29	10.51	16.75
Net Profit	25.53+118.4%	43.47	24.92	19.24	11.69	99.31
NPM	14.08	16.49	13.85	9.99	8.36	12.73
EPS	19.10+118.3%	32.51	18.64	14.40	8.75	74.29

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 18-19	FY 17-18	FY 16-17
Revenue	768.73+20.2%	639.46+11.2%	575.21	301.84-15.0%	355.07-5.4%	375.45
Other Income	11.45	20.78	11.32	4.51	0.72	0.79
Total Income	780.18+18.2%	660.24+12.6%	586.53	306.35-13.9%	355.79-5.4%	376.24
Expenditure	-649.50-9.9%	-591.09-9.5%	-539.88	-325.65+6.0%	-346.49-3.7%	-333.97
Interest	0	0	0	-25.15	-34.98	0
PBDT	0	0	0	0	9.30	1.04
EBITDA	143.92+105.6%	69.99+15.0%	60.88	34.29-55.1%	76.29+83.9%	41.48
Depreciation	-24.69	-21.62	-25.55	-32.95	-32.73	0
EBIT	119.23+146.5%	48.37+36.9%	35.33	1.34-96.9%	43.56+5.0%	41.48
PBT	130.68+65.3%	79.06+69.5%	46.65	-28.26-20.7%	-23.42-2351.9%	1.04
Tax	-31.37	-23.58	-16.15	1.15	-3.16	3.70
Equity	13.37	13.37	0	0	12.34	12.34
OPM (%)	16.75	11.97	8.00	-9.00	2.62	0.28
Net Profit	99.31+89.0%	52.55+72.3%	30.50	-27.11-2.0%	-26.58-659.6%	4.75
NPM (%)	12.73	7.96	5.00	-9.00	-7.49	1.26
EPS (Rs)	74.29+88.9%	39.32+72.3%	22.82	-21.97-2.0%	-21.54	0
CEPS	74.29	39.32	22.82	-21.97	4.98	3.85

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	178.86+35.6%	259.40	180.26	192.75	131.90	769.60
Other Income	2.62	4.95	2.52	1.71	8.69	12.58
Total Income	181.48+29.1%	264.35	182.78	194.46	140.59	782.18
Interest	0	0.01	0.01	0.01	0.01	0.04
Expenditure	-151.44-18.3%	-202.75	-149.31	-167.97	-127.98	-648.03
PBDT	0	0	0	0	0	0
EBITDA	34.19+238.2%	63.42	37.52	30.96	10.11	147.28
Depreciation	-6.77	-6.76	-6.56	-6.17	-6.18	-25.67
EBIT	27.42+597.7%	56.66	30.96	24.79	3.93	121.61
PBT	30.04+138.2%	61.60	33.47	26.49	12.61	134.15
Tax	-7.07	-14.11	-7.89	-6.36	-3.01	-31.37
Equity	13.37	13.37	0	0	13.37	13.37
OPM	16.55	23.30	18.31	13.62	8.97	17.15
Net Profit	22.97+139.3%	47.49	25.58	20.13	9.60	102.78
NPM	12.66	17.96	13.99	10.35	6.83	13.14
EPS	17.18+139.3%	35.53	19.14	15.06	7.18	76.89

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 18-19
Revenue	769.60+18.8%	647.89+7.7%	601.45	321.89
Other Income	12.58	20.96	11.58	6.09
Total Income	782.18+16.9%	668.85+9.1%	613.03	327.99
Expenditure	-648.03-6.8%	-606.93-6.8%	-568.38	-348.75
Interest	-0.04	-0.07	-0.09	-25.41
PBDT	0	0	0	0
EBITDA	147.28+131.8%	63.54+6.6%	59.60	32.53
Depreciation	-25.67	-22.51	-26.44	-33.98
EBIT	121.61+196.4%	41.03+23.7%	33.16	-1.45
PBT	134.15+86.8%	71.83+60.9%	44.65	-29.73
Tax	-31.37	-23.58	-16.15	1.15
Equity	13.37	13.37	0	0
OPM (%)	17.15	10.74	7.28	-9.06
Net Profit	102.78+126.8%	45.32+59.0%	28.50	-28.58
NPM (%)	13.14	6.78	4.65	-8.71
EPS (Rs)	76.89+126.8%	33.90+59.1%	21.31	-23.15
CEPS	76.89	33.90	21.31	-23.15

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	10	07 Aug 2026
2013	Final Dividend	3	23 Sep 2013
2012	Final Dividend	3	20 Sep 2012
2011	Final Dividend	3	22 Sep 2011
2010	Final Dividend	3	23 Sep 2010
2009	Final Dividend	3	17 Sep 2009
2008	Final Dividend	4	12 Sep 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split